Shell Plc

Income statement and earnings

Sources and verification: FY2023–FY2025 income, Adjusted Earnings, CFFO and capex from FY2025 Form 20-F key metrics [V]; FY2025 total revenue and other income $273.7bn and FY2024 $289.1bn per Offshore Technology summary of Q4 2025 results [V]; FY2025 net debt $45.7bn and gearing 20.7% [V]; FY2024 net debt $38.8bn and gearing 17.7% [V]; FY2021–FY2022 figures and FY2023 net debt/gearing and revenue [R]. Dividends per share are the sum of the four quarterly interim dividends declared for each year; FY2025 Q2 ($0.358) and Q4 ($0.372) [V], other quarters [R].

Revenue CAGR FY2021–FY2025 (total revenue and other income): approximately +0.1% p.a. (derived: 272.7 → 273.7). The flat endpoint masks a 2022 price spike (+42%) and three subsequent years of decline (-16%, -11%, -5%).

Derived margins (calculated from the tables above; not Shell-reported)

Adjusted EBITDA margin (derived): 21.2% FY2023, 22.8% FY2024, 20.5% FY2025.

Gross profit and operating income are not meaningful Shell disclosures (Shell presents a nature-of-expense income statement); they are therefore not presented.

Earnings per share

Diluted EPS (attributable): FY2021 $2.57, FY2022 $5.71, FY2023 $2.85, FY2024 $2.55 [R]. Basic EPS differs from diluted by ~$0.01–0.02 per year [R] and is not separately tabulated.

Balance sheet and leverage

Sources: Q2 2026 unaudited results and press release [V]. Net debt excluding leases was ~$12bn at end-Q2 2026 [V], i.e., roughly $30bn of reported net debt is lease liabilities (largely long-term LNG shipping charters).

Cash returns

• FY2025 total shareholder distributions exceeded $22bn, equal to 52% of CFFO [V].

• Q2 2026: CFFO $21.4bn (including a $3.4bn working-capital inflow), free cash flow $17.5bn, distributions over the trailing 12 months equal to 44% of CFFO [V].

• 19 consecutive quarters of announced buybacks of at least $3bn through Q2 2026 [V].

Ratios (derived unless stated)

Shell reports ROACE in its annual report; consult the FY2025 20-F.

Commentary on trends and inflections

1. Price-driven cyclicality dominates. FY2022 Adjusted Earnings ($39.9bn) were more than double FY2025's ($18.5bn) [R/V], a range explained mostly by Brent and LNG prices rather than volumes.

2. Cost discipline is real but secondary. $5.8bn of structural cost reductions were delivered by mid-2026 versus the 2022 baseline (against a $5–7bn 2028 target) [V], cushioning FY2025's price decline.

3. Capex discipline then a step-up. Cash capex fell from $24.4bn (FY2023) to $20.9bn (FY2025) [V]; FY2026 guidance rose to $24–26bn including ~$4bn for the ARC cash consideration, with 2027–2028 unchanged at $20–22bn [V].

4. 2026 inflection. H1 2026 income attributable was $16.5bn and Adjusted EBITDA $38.5bn, versus $8.4bn and $28.6bn in H1 2025 [V], driven by war-related price spikes, refining margins and trading.

5. Working capital volatility. Q1 2026 saw an $11.2bn working-capital outflow as commodity prices spiked; Q2 2026 reversed $3.4bn of it [V]. Shell's net debt therefore swung from $45.7bn to $52.6bn and back to $41.8bn within two quarters [V].

Management guidance (latest)

• Q3 2026 (Update Note, 7 Oct 2026) [V]: IG production 740–780 kboe/d (incl. ARC from 2 Sep); LNG liquefaction 7.2–7.6 Mt; IG trading in line with Q2; Upstream production 1,735–1,835 kboe/d; Marketing earnings lower than Q2; refining margin $42/bbl; chemicals margin $208/t; refinery utilisation 93–97%; C&P trading in line with Q2; R&ES $0.0–0.4bn; Corporate -$0.6 to -$0.8bn; working capital -$4bn to +$1bn; ~$2.5bn BEHG outflow; net debt to rise on ARC cash and assumed debt plus higher shipping-lease costs.

• FY2026 capex $24–26bn; FY2027–2028 $20–22bn [V].

Bull case

1. Refining tailwind: a 75% jump in indicative refining margin into Q3 2026 ($24 → $42/bbl) [V] with trading in line with a record Q2 suggests another strong Products quarter.

2. Volume growth locked in: ARC (+~370 kboe/d) and LNG Canada at capacity underpin a ~4% production CAGR to 2030 [V], with Pearl GTL recovery adding back volumes in 2027.

3. Valuation: ~8x 2026e P/E [V] for a company that generated $26bn FCF in a weak year [V] and keeps returning 40–50% of CFFO.

Bear case

1. Peak earnings: Q2 2026's $9.8bn was the best quarter since 2022 [V]; with Brent back near $73 [V – media] and chemicals margins softening [V], 2027 consensus (P/E ~9.5x) already implies decline.

2. Dilution and leverage: ~$10.6bn of new shares issued for ARC [V] and lease-driven net debt growth [V] dilute per-share metrics until 2027 accretion.

3. Legal and geopolitical tail risks: a second Dutch climate case targeting new fields [V] and continued Gulf exposure [V].

Catalysts and monitorables (next 12 months)

• 29 Oct 2026: Q3 2026 results, Q4 buyback size, net debt post-ARC [V].

• Pearl GTL Train 2 repair timeline and insurance recoveries.

• ARC purchase price allocation and synergy disclosure.

• Completion of TotalEnergies renewables sale (end-2026) [V].

• Q4 2025-style annual dividend decision in February 2027.

• Dutch court milestones in both Milieudefensie cases.

• Capital Markets Day update (if any) on post-ARC targets.

Analyst verdict

Shell enters the final quarter of 2026 in a stronger strategic position than at any time since the BG Group deal. The Sawan programme has done what it promised: costs are $5.8bn lower than in 2022, the portfolio is shorn of Nigeria onshore, Singapore chemicals, Canadian oil sands, Indian and European onshore renewables, and the balance sheet is conservatively geared at 18.7%. The 2026 shock — a regional war that knocked out Pearl GTL and Qatari LNG — paradoxically showcased the model's resilience: trading and record operational performance elsewhere delivered $16.8bn of Adjusted Earnings in the first half, close to the whole of 2025.

The ARC acquisition is the defining capital-allocation call. Paid largely in stock, it trades buyback capacity for long-duration, low-cost Montney liquids and gas that integrate naturally with LNG Canada. If management delivers the promised double-digit returns and FCF-per-share accretion from 2027, it reframes Shell from a cash-return story into a modest-growth one, with production compounding near 4% a year to 2030.

The risks are real but bounded. Earnings are near a cyclical peak; Brent has retreated, chemicals remain loss-prone, lease-heavy net debt will rise after ARC, and Dutch litigation now targets the growth pipeline directly. The executive-pay increase, though overwhelmingly approved by shareholders, will keep governance under scrutiny.

On balance, at roughly eight times 2026 consensus earnings with a ~3.5% dividend yield and buybacks running at $3bn-plus a quarter, the market appears to price Shell for normalisation rather than growth. The asymmetry favours patient holders, provided management sustains capex discipline at $20–22bn from 2027 and keeps distributions within the 40–50% framework. Our synthesis: constructive, with a moderate-risk profile; the October 29 results and the first post-ARC net-debt print are the near-term tests. This is an analytical synthesis, not personalised investment advice.